Advertisement
Screener

BIOLARGO, INC. (BLGO) Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest

2.9 / 5 stars · 47/80 Roast Me

BIOLARGO, INC. Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest

BIOLARGO, INC. (BLGO) reported Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest of -$4.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Shareholders' Equity

us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest · last filed 2026-08-14

  • BIOLARGO, INC. net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2026-06-30 was -$4.00M.
  • BIOLARGO, INC. net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2026-03-31 was -$3.40M.
  • BIOLARGO, INC. net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2025-09-30 was -$7.24M.
  • BIOLARGO, INC. net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2025-06-30 was -$1.88M.
Period endNet Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 3 monthNet Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 6 monthNet Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 9 monthNet Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 12 month
2026-06-30-$4.00M
10-Q · filed 2026-08-14
-$7.41M
derived: sum of 2 quarters · filed 2026-08-14
2026-03-31-$3.40M
10-Q · filed 2026-08-14
2025-12-31-$15.19M
S-1 · filed 2026-04-09
2025-09-30-$7.24M
10-Q · filed 2025-11-14
-$9.13M
derived: sum of 2 quarters · filed 2026-08-14
-$11.05M
derived: sum of 3 quarters · filed 2026-08-14
2025-06-30-$1.88M
10-Q · filed 2026-08-14
-$3.80M
derived: sum of 2 quarters · filed 2026-08-14
2025-03-31-$1.92M
10-Q · filed 2026-08-14
2024-12-31-$4.35M
S-1 · filed 2026-04-09
2024-09-30-$1.06M
10-Q · filed 2025-11-14
-$1.84M
derived: sum of 2 quarters · filed 2025-11-14
-$2.62M
derived: sum of 3 quarters · filed 2025-11-14
2024-06-30-$780.00K
10-Q · filed 2025-11-14
-$1.55M
derived: sum of 2 quarters · filed 2025-11-14
2024-03-31-$775.00K
10-Q · filed 2025-11-14